Fady Ibraham Malik, EVP Research & Development at CYTOKINETICS INC (CYTK), sold 3,500 shares at $65.69 ($230K) on 2026-04-21, disclosed to the SEC on 2026-04-21.
Seasonal sale ($230k) by EVP Research & Development — this insider has traded CYTK in April in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| CYTK | SELL | 2026-09-08 | $264K | — | Filing → |
| CYTK | SELL | 2026-08-18 | $265K | — | Filing → |
| CYTK | SELL | 2026-07-23 | $282K | — | Filing → |